Lynn A. Tetrault

Director

Director at RHYTHM PHARMACEUTICALS, INC., filing insider transactions between 2026-06-09 and 2026-06-22. Also reports transactions at 1 other company.

Total Purchases

—

0 transactions

Total Sales

$3.8M

3 transactions

Companies Traded

3 total filings

Active Since

2026-06-09

Last: 2026-06-22

Companies

RYTM2026-06-22

RHYTHM PHARMACEUTICALS, INC.

↓ $3.7M (1)

NEO2026-06-15

NEOGENOMICS INC

↓ $119K (2)

Other Reporting Insiders at Rhythm Pharmaceuticals, Inc.

David P. Meeker
Director & President and CEO
Last filing 2026-09-14
Hunter C. Smith
Chief Financial Officer
Last filing 2026-08-31
Joseph Shulman
Chief Technical Officer
Last filing 2026-08-13
Jennifer Kayden Lee
EVP, Head of North America
Last filing 2026-08-13
Alastair Garfield
Chief Scientific Officer
Last filing 2026-08-13
Yann Mazabraud
EVP, Head of International
Last filing 2026-08-12
Christopher Paul German
Corporate Controller & CAO

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-22	RYTM	Sale	37.0K	$100.32	$3.7M	7,000	SEC ↗
2026-06-15	NEO	Sale	5,307	$11.10	$59K	86.1K	SEC ↗
2026-06-09	NEO	Sale	5,307	$11.29	$60K	91.4K